Skip to main content
Clinical Trials/DRKS00024861
DRKS00024861
Completed
未知

Randomized controlled trial to evaluate the digital health application My Dose Coach

Sanofi-Aventis Deutschland GmbH0 sites251 target enrollmentApril 13, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
E11
Sponsor
Sanofi-Aventis Deutschland GmbH
Enrollment
251
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 13, 2021
End Date
July 12, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Diagnosed type 2 diabetes (E11\)
  • \- Indication for therapy with basal insulin in combination with oral antidiabetic agents
  • \- Age \= 18 years
  • \- HbA1c value\> 7\.5% or 58\.5 mmol / mol and \<10\.0% or 85\.6 mmol / mol (last measured HbA1c value from the patient file)
  • \- Use of a smartphone compatible with the My Dose Coach app (iPhone models 5 and higher with iOS 10 or higher; Android version 4\.4 or higher)
  • \- Willingness to consent to the terms and conditions of the My Dose Coach app
  • \- Knowledge of German, spoken and written
  • \- Existence of a written declaration of consent for participation in the study

Exclusion Criteria

  • \- Treatment with prandial insulin (mealtime insulin)
  • \- Body Mass Index (BMI) \<25 kg / m2
  • \- Renal insufficiency (GFR \<30 ml / min)
  • \- The presence of an acute psychiatric illness which, in the opinion of the investigator, affects the patient's ability to properly carry out the diabetes therapy or the study
  • \- Use of another titration app
  • \- Lack of consent due to limited legal capacity or legal support
  • \- Dependency on the sponsor or the clinical investigator (e.g. employees of the sponsor or a trial center and their family members)
  • \- Simultaneous participation in another clinical study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Randomized controlled trial to evaluate the digital health application mySugr PROE10E11O24.4Type 1 diabetes mellitusType 2 diabetes mellitusDiabetes mellitus arising in pregnancy
DRKS00022923Roche Diabetes Care GmbH - DCSDB424
Active, not recruiting
Not Applicable
A randomized controlled study to evaluate a digital intervention for treating anxiety disorders in adultsTreatment of anxiety disorders in patients on the waiting list for the outpatient psychotherapeutic treatmentMental and Behavioural Disorders
ISRCTN12481277Elona Health GmbH158
Active, not recruiting
Not Applicable
A randomized controlled study to evaluate a digital intervention for treating unipolar depression in adultsTreatment of unipolar depression in patients on the waiting list for the outpatient psychotherapeutic treatmentMental and Behavioural Disorders
ISRCTN54139009Elona Health GmbH158
Active, not recruiting
Not Applicable
A randomized controlled study to evaluate a digital intervention for treating adjustment disorders in adultsTreatment of adjustment disorders in patients on the waiting list for the outpatient psychotherapeutic treatmentMental and Behavioural Disorders
ISRCTN16971578Elona Health GmbH158
Recruiting
Not Applicable
A randomised control trial of digital memory flexibility training (MemFlex) as a stepped care intervention for individuals with post-traumatic stress disorder (PTSD)Post-traumatic stress disorderMental Health - Other mental health disorders
ACTRN12624000566538The University of Melbourne40